Skip to main content
Fig. 4 | BMC Neuroscience

Fig. 4

From: Neuropathological changes in dorsal root ganglia induced by pyridoxine in dogs

Fig. 4

GFAP immunostaining of the DRG in control (a, e, i) and PDX-treated (bd, fh, jl) groups. In the control group, GFAP immunoreactivity is shown in the DRG and GFAP immunoreactive satellite glial cells are abundant at 1 week after the last PDX treatment, after which the abundance decreased with time. Scale bar = 100 μm. M: Relative optical density (ROD; as a percentage) of each DRG region of the control group (n = 2–3 per group; aP < 0.05, significantly different from the control group; bP < 0.05, significantly different from the 1 day after the last PDX treatment group; cP < 0.05, significantly different from the 1 week after the last PDX treatment group). The bars indicate mean ± SEM values

Back to article page